Top

Reactions Weekly

Published in:

01-11-2022 | NSCLC | Case report

Pembrolizumab

Pneumonitis: case report

Published in: Reactions Weekly | Issue 1/2022

Excerpt

Author Information

An event is serious (based on the ICH definition) when the patient outcome is&colon;

* death
* life-threatening
* hospitalisation
* disability
* congenital anomaly
* other medically important event

…

Ortega-Franco A, et al. Real-World Data on Pembrolizumab for Pretreated Non-Small-Cell Lung Cancer: Clinical Outcome and Relevance of the Lung Immune Prognostic Index. Targeted Oncology 17: 453-465, No. 4, Jul 2022. Available from: URL: http://doi.org/10.1007/s11523-022-00889-8

Title: Pembrolizumab
Pneumonitis: case report
Publication date: 01-11-2022
Publisher: Springer International Publishing
Keywords: NSCLC
NSCLC
Published in: Reactions Weekly / Issue 1/2022
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-022-27284-2

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Pembrolizumab

Pneumonitis: case report

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2022

Multiple drugs

Multiple drugs

Voriconazole-related hepatotoxicity in Chinese patients

Rituximab

Antineoplastics

Multiple drugs